Investor Relations, M&A & Strategic Partnerships

An independently developed Belgian medical e-commerce and distribution business, open to selected strategic partnerships, investment opportunities and potential acquisition discussions.

Corporate Overview

Belgomedical is a Belgian medical e-commerce and distribution business, operating as a division of E.B.Materials bv. Established in 2003, the company has developed a specialised online distribution platform serving individual consumers, healthcare professionals and institutional customers.

The business combines medical product knowledge, international online sales, multilingual customer service and an established e-commerce infrastructure. Its activities include both B2C (business-to-consumer) and B2B (business-to-business) distribution.

Belgomedical has been independently financed and developed, without reliance on external investors. The company has built its operations around a lean structure, controlled costs and a long-term approach to sustainable business development.

Business Model & Competitive Advantages

Lean Operating Structure

A cost-conscious business model supported by an efficient online sales and order-processing infrastructure.

Organic Customer Acquisition

Customer acquisition is primarily driven by organic search visibility and established online content, with minimal reliance on paid search advertising.

International Reach

An international customer base supported by multilingual online sales, customer communication and distribution activities.

Digital Scalability & Boundless E-commerce Infrastructure

Belgomedical's e-commerce infrastructure is designed for extensive scalability. It supports virtually unlimited product catalogue expansion and allows additional languages and international markets to be introduced without requiring a separate webshop infrastructure for each expansion.

This provides a flexible digital foundation for substantial business growth, product diversification and international market development. The platform can accommodate a growing product range and an expanding multilingual online presence, offering considerable scope for further commercial development.

Combined with an established organic search-led customer acquisition model, this infrastructure offers opportunities for further digital development and international distribution growth. The scalability of the platform provides a strong basis for expansion, while operational, logistical and regulatory requirements remain part of any market development strategy.

Integrated B2C & B2B Medical Distribution

The webshop combines transparent B2C retail pricing with flexible commercial conditions for professional customers and healthcare institutions.

B2B customers can benefit from preferential pricing through discounts applied directly at checkout or by requesting tailored quotations for larger orders and institutional requirements. This allows Belgomedical to serve individual consumers and professional buyers through the same e-commerce infrastructure, while accommodating different purchasing volumes and commercial needs.

The integrated model provides a basis for further development of professional distribution relationships, institutional sales and international B2B partnerships.

Medical Distribution & Regulatory Experience

Belgomedical has experience in the distribution and commercialisation of medical products within the European market. Its activities include working with relevant product requirements, medical device documentation and applicable European and Belgian regulatory obligations.

E.B.Materials bv is registered in Belgium for the distribution of medical devices under FAGG registration number BE/CA01/1-11763. This experience provides a foundation for cooperation with medical product manufacturers, distributors and other healthcare businesses.

Strategic Investment & M&A Opportunities

Belgomedical is an independently developed and profitable medical e-commerce and distribution business. The company is open to exploring selected strategic opportunities that could support its further development or create value through cooperation with complementary businesses.

We welcome confidential enquiries from:

  • Strategic investors and institutional investors
  • Private equity firms and investment groups
  • Medical distributors and healthcare companies
  • International MedTech groups and medical distribution consolidators
  • Companies considering international expansion or complementary acquisitions
  • M&A advisors and corporate development professionals

Potential areas of interest may include strategic investment, business acquisition, mergers and acquisitions (M&A), international joint ventures, business combinations, distribution partnerships or a potential full acquisition.

Belgomedical is not presenting a predefined transaction structure. The company is open to discussing suitable opportunities on a confidential basis with serious and relevant parties.

Corporate & Financial Information

Trading name Belgomedical
Legal entity E.B.Materials bv
Country Belgium
Established 2003
Online operations Since 2005
Company number BE 0859.589.551
Business activities Medical e-commerce and distribution

The company's annual accounts are filed with the National Bank of Belgium (NBB) and are publicly available through the Belgian company accounts registry. The preparation of the annual accounts is carried out with the assistance of an external accounting firm.

Further financial information, historical performance figures and additional business details can be made available to qualified parties upon request, subject to appropriate confidentiality arrangements.

Confidential Acquisition & Partnership Enquiries

For strategic investment, M&A, business acquisition, international distribution or partnership enquiries, please contact Belgomedical directly.

Contact Belgomedical

All strategic and acquisition enquiries will be treated confidentially.